TCT-734 Impact of Stent Length on 5-year Clinical Outcomes following Second-generation Drug-eluting Stents Implantation

Background Stent length is one of the predictors of adverse clinical outcomes after percutaneous coronary intervention (PCI) with the bare-metal and first-generation drug eluting stents (DES). Methods A total of 472 patients with 899 de novo coronary lesions underwent PCI with second generation DESs...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.B312-B312
Main Authors: Mashaly, Ahmed, Rha, Seung-Woon, Choi, Byoung Geol, Choi, Se Yeon, Byun, Jae Kyeong, Jang, Won Young, Kim, Woo Hyeun, Park, Eun Jin, Choi, Ja Yeon, Na, Jin Oh, Choi, Cheol Ung, Lim, Hong Euy, Kim, Eung Ju, Park, Chang Gyu, Seo, Hong-Seog, Oh, Dong Joo
Format: Article
Language:English
Subjects:
Cardiology
Clinical outcomes
Drug delivery
Implantation
Implants
Stents
Surgical implants
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Stent length is one of the predictors of adverse clinical outcomes after percutaneous coronary intervention (PCI) with the bare-metal and first-generation drug eluting stents (DES). Methods A total of 472 patients with 899 de novo coronary lesions underwent PCI with second generation DESs were divided into two groups acording to the stent length: 1) Short stent group (stent length = 32mm, n:168).
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2017.09.969